Caribou Biosciences(CRBU) - 2023 Q3 - Quarterly Report

Cash Used in Operating Activities 32 During the nine months ended September 30, 2023, cash used in investing activities was $36.7 million, and during the nine months ended September 30, 2022, cash used in investing activities was$94.4 million. During the nine months ended September 30, 2023, and 2022, cash provided by financing activities was $154.3 million and$2.0 million, respectively. Our critical accounting policies are disclosed in our audited consolidated financial statements for the year ended Dece ...